Acknowledgement
This paper was supported by the Konyang University Research Fund in 2021.
References
- Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18:225-242. https://doi.org/10.1038/nri.2017.125
- Lenz KM, Nelson LH. Microglia and beyond: innate immune cells as regulators of brain development and behavioral function. Front Immunol. 2018;9:698. https://doi.org/10.3389/fimmu.2018.00698
- Lively S, Schlichter LC. Microglia responses to pro-inflammatory stimuli (LPS, IFNγ+ TNFα) and reprogramming by resolving cytokines (IL-4, IL-10). Front Cell Neurosci. 2018;12:215. https://doi.org/10.3389/fncel.2018.00215
- Batista CRA, Gomes GF, Candelario-Jalil E, Fiebich BL, De Oliveira ACP. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration. Int J of Mol Sci. 2019;20:2293. https://doi.org/10.3390/ijms20092293
- O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402. https://doi.org/10.3389/fendo.2018.00402
- Zhao C, Sun X, Li L. Biogenesis and function of extracellular miRNAs. ExRNA. 2019;1:1-9. https://doi.org/10.1186/s41544-019-0039-4
- Zhao J, Wang H, Dong L, Sun S, Li L. miRNA-20b inhibits cerebral ischemia-induced inflammation through targeting NLRP3. Int J Mol Med. 2019;43:1167-1178. https://doi.org/10.3892/ijmm.2018.4043
- Fu X, Shen YI, Wang W, Li X. MiR-30a-5p ameliorates spinal cord injury-induced inflammatory responses and oxidative stress by targeting Neurod 1 through MAPK/ERK signalling. Clin Exp Pharmacol Physiol. 2018;45:68-74. https://doi.org/10.1111/1440-1681.12856
- Jin Y, Yao G, Wang Y, Teng L, Wang Y, Chen H, et al. MiR-30c-5p mediates inflammatory responses and promotes microglia survival by targeting eIF2α during Cryptococcus neoformans infection. Microb Pathog. 2020;141:103959. https://doi.org/10.1016/j.micpath.2019.103959
- Yang L, Ge D, Chen X, Jiang C, Zheng S. miRNA-544a regulates the inflammation of spinal cord injury by inhibiting the expression of NEUROD4. Cell Physiol Biochem. 2018;51:1921-1931. https://doi.org/10.1159/000495717
- Fukuda M, Vazquez AL, Zong X, Kim SG. Effects of the α2-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex. Eur J Neurosci. 2013;37:80-95. https://doi.org/10.1111/ejn.12024
- Wen W, Gong X, Cheung H, Yang Y, Cai M, Zheng J, et al. Dexmedetomidine alleviates microglia-induced spinal inflammation and hyperalgesia in neonatal rats by systemic lipopolysaccharide exposure. Front Cell Neurosci. 2021;15:725267. https://doi.org/10.3389/fncel.2021.725267
- Gao J, Sun Z, Xiao Z, Du Q, Niu X, Wang G, et al. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Br J Anaesth. 2019;123:827-838. https://doi.org/10.1016/j.bja.2019.08.026
- Zhou XY, Liu J, Xu ZP, Fu Q, Wang PQ, Zhang H. Dexmedetomidine inhibits the lipopolysaccharide-stimulated inflammatory response in microglia through the pathway involving TLR4 and NF- κB. The Kaohsiung J Med Sci. 2019;35:750-756. https://doi.org/10.1002/kjm2.12112
- Meng F, Yu W, Duan W, Wang T, Liu Y. Dexmedetomidine attenuates LPS-mediated BV2 microglia cells inflammation via inhibition of glycolysis. Fundam Clin Pharmacol. 2020;34:313-320. https://doi.org/10.1111/fcp.12528
- Zhang L, Xiao F, Zhang J, Wang X, Ying J, Wei G, et al. Dexmedetomidine mitigated NLRP3-mediated neuroinflammation via the ubiquitin-autophagy pathway to improve perioperative neurocognitive disorder in mice. Front Pharmacol. 2021;12:1143. https://doi.org/10.3389/fphar.2021.646265
- Li H, Zhang X, Chen M, Chen J, Gao T, Yao S. Dexmedetomidine inhibits inflammation in microglia cells under stimulation of LPS and ATP by c-Fos/NLRP3/caspase-1 cascades. EXCLI J. 2018;17:302. https://doi.org/ 10.17179/excli2017-1018
- Qiu Z, Lu P, Wang K, Zhao X, Li Q, Wen J, et al. Dexmedetomidine inhibits neuroinflammation by altering microglial M1/M2 polarization through MAPK/ERK pathway. Neurochem Res. 2020;45:345-353. https://doi.org/10.1007/s11064-019-02922-1
- Cho KJ, Song J, Oh Y, Lee JE. MicroRNA-Let-7a regulates the function of microglia in inflammation. Mol Cell Neurosci. 2015; 68:167-176. https://doi.org/10.1016/j.mcn.2015.07.004
- Bao Y, Zhu Y, He G, Ni H, Liu C, Ma L, et al. Dexmedetomidine attenuates neuroinflammation in LPS-stimulated BV2 microglia cells through upregulation of miR-340. Drug Des Devel Ther. 2019;13:3465. https://doi.org/10.2147/DDDT.S210511
- Li P, Yao Y, Ma Y, Chen Y. MiR-30a-5p ameliorates LPS-induced inflammatory injury in human A549 cells and mice via targeting RUNX2. Innate Immun. 2021;27:41-49. https://doi.org/10.1177/1753425920971347
- Li L, Kang L, Zhao W, Feng Y, Liu W, Wang T, et al. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Cancer Lett. 2017;400:89-98. https://doi.org/10.1016/j.canlet.2017.04.034
- Zhang S, Han L, Wei J, Shi Z, Pu P, Zhang J, et al. Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes. Int J of Oncol. 2015;46:1589-1600. https://doi.org/10.3892/ijo.2015.2841
- Deng Y, Cai L, Wang F, Huang J, Wang H, Li L, et al. Upregulated microRNA-381-5p strengthens the effect of dexmedetomidine preconditioning to protect against myocardial ischemia-reperfusion injury in mouse models by inhibiting CHI3L1. Int Immunopharmacol. 2021;92:107326. https://doi.org/10.1016/j.intimp.2020.107326